BioSpace News Archive

International Stem Cell Corporation announced today that Lifeline Cell Technology (LCT), has expanded its business and manufacturing capabilities to fulfill current and forecasted demand.

Recursion announced the company has appointed Tina M. Larson as Chief Operating Officer.

The specialty pharmacy uses AdhereTech smart pill bottles for multiple specialty medications from various manufacturers, with consistent improvements in adherence, duration, refills, and the patient experience.

Top-line data for LIBERTY 1 expected in second quarter of 2019

Kraig Biocraft Laboratories, Inc. announces that, during its trip to Vietnam last week, the Company celebrated the grand opening of Prodigy Textiles’ new facility in Quang Nam province.

Next-generation endocrine therapy exhibits differentiated mechanism of action versus standard-of-care therapies and potently inhibits the ERα pathway

PMN310 Shows Potential for Best in Class Amyloid-Beta Oligomer Selectivity

Knockout Validation of Antibodies Confirms Specificity and Ensures Reproducible Results

Allogene Therapeutics, Inc. announced its Scientific Advisory Board (SAB), which is comprised of five experts in oncology, immunology, drug discovery and development.

Correvio Pharma Corp. announced that it has entered into an At the Market Sales Issuance Agreement dated July 10, 2018 (the “Sales Agreement”) with B. Riley FBR, Inc. (“BRFBR”) as agent, pursuant to which the Company may, from time to time sell, through “at-the-market” offerings on the Nasdaq Capital Market